Climate Change Is Emerging as a Structural Threat to Tuberculosis Control
Climate change is no longer a distant environmental concern for tuberculosis control. In a WHO-commissioned analytical framework, investigators mapped how shifting temperatures, rainfall patterns, food insecurity, displacement, and health-system disruption could intensify the conditions that allow tuberculosis to spread, persist, and kill. The central message is stark: TB has been largely absent from climate-health planning despite its dependence on the very social and biological determinants most vulnerable to climate stress.
The analysis did not identify direct studies linking climate change with tuberculosis outcomes. That absence should not be mistaken for absence of risk. Instead, the framework assembled indirect evidence from established TB determinants and traced plausible pathways through which climate-related shocks may worsen exposure, progression from infection to disease, delayed diagnosis, treatment interruption, and poor survival.
Tuberculosis already sits at the intersection of poverty, crowded housing, undernutrition, migration, and fragile care access. Climate change acts on each of those layers at once.
Determinants of TB That Climate Stress Can Rewire
The framework begins with a simple clinical observation: TB transmission and progression are not driven by biology alone. They are shaped by nutritional status, indoor crowding, air quality, population movement, and the ability of health systems to find and treat infected people early. Climate-sensitive shocks can destabilize all of these determinants simultaneously.
Food insecurity is one of the clearest examples. Drought, crop failure, and disrupted supply chains can worsen undernutrition, and undernutrition is a well-established risk factor for progression from latent infection to active disease. In practical terms, a person exposed to Mycobacterium tuberculosis is less able to contain infection when caloric intake and micronutrient stores collapse. Climate-related economic stress can also deepen poverty, which in turn increases overcrowding and reduces access to care, creating a favorable environment for transmission.
Displacement adds another layer. Floods, heat waves, storms, and long-term environmental degradation can force families to move into shelters or informal settlements where ventilation is poor and health services are fragmented. In those settings, prolonged exposure and delayed symptom recognition can turn one untreated case into several. The framework treats migration not as a side effect of climate change, but as a mechanistic bridge between environmental disruption and TB epidemiology.
Health-System Fragility Can Turn Climate Events Into TB Interruptions
Climate stress does not need to alter bacterial virulence to worsen TB outcomes. It can simply break the systems that detect disease and deliver therapy. Extreme weather events can damage clinics, interrupt supply chains for diagnostic reagents and medicines, and make routine follow-up impossible. Heat and travel disruption can keep symptomatic patients from reaching care, while service diversion toward acute disaster response can delay TB screening and treatment initiation.
Those failures carry clinical consequences. TB therapy depends on continuity. Missed diagnosis prolongs infectiousness; interrupted treatment raises the risk of poor outcomes and ongoing community transmission. In regions already managing drug-resistant disease, any further instability can magnify the cost of delay. The framework therefore treats health-system resilience as a TB intervention, not merely an administrative goal.
Diagnostic pathways are vulnerable as well. Respiratory symptoms may be misattributed during periods of wildfire smoke, heat-related illness, or overlapping infection outbreaks. When health services are overstretched, TB can disappear into diagnostic noise. A patient with weight loss, fever, and cough does not benefit from a climate-blind triage system.
Indirect Evidence Supports Plausible Causal Links
Although no direct epidemiologic studies connected climate change to TB in this review, the assembled evidence pointed in the same direction across multiple pathways. The mechanistic chain is biologically credible: climate change can increase undernutrition, displacement, crowding, air pollution exposure, and health-system disruption; each of those factors independently increases the risk of TB transmission or progression. The framework is careful not to overclaim, but it does establish that the absence of direct studies is a research gap, not a reason for inaction.
This matters because TB already causes more deaths from a single infectious agent than any other disease. A climate policy that ignores TB leaves one of the world’s most consequential infections outside the adaptation plan. That omission is especially concerning in high-burden countries where climate vulnerability and TB incidence overlap geographically and socially.
The review also points to a broader equity issue. Communities most exposed to climate shocks often have the least resilient health infrastructure and the greatest baseline TB burden. When climate adaptation is designed without TB, the burden is likely to fall hardest on people already facing structural disadvantage.
Why Climate-Resilient TB Policy Needs to Start Now
The framework argues for including tuberculosis in climate risk adaptation, mitigation, and financing mechanisms. In clinical terms, that means TB programs need to be designed as climate-resilient systems: services that can continue during heat extremes, flooding, displacement, and supply-chain disruption. It also means surveillance, prevention, and treatment must be integrated into broader emergency preparedness plans rather than treated as separate vertical programs.
Research priorities follow naturally from that argument. The field needs studies that can quantify how climate variables influence TB incidence, case detection, treatment adherence, and mortality over time and across settings. It also needs better modeling of how changes in food systems, migration, and air quality alter TB risk at population level. Without those data, policy will continue to lag behind the scale of the threat.
Directly linking climate adaptation funding to TB control would also close a dangerous gap. If climate finance supports only infrastructure and disaster response while neglecting infectious disease control, the health burden of climate change will persist long after the weather event ends. TB must be considered part of that burden.
The framework ends with a clear warning: climate change could become a barrier to ending the global TB epidemic unless research and action move together. The most immediate limitation is the absence of direct causal studies, which leaves many estimates inferential rather than measured. Even so, the biological and social pathways are already strong enough to justify clinical and policy planning now, before more climate-related disruption is translated into missed diagnoses, treatment failures, and preventable deaths.